Literature DB >> 14584399

[Cyclosporin improved pure red cell aplasia associated with thymoma and tended to decrease thymoma size: a case report].

Hirofumi Mochizuki1, Tsuneto Okada, Hirohisa Yoshizawa, Eiichi Suzuki, Fumitake Gejyo.   

Abstract

The case was a 56-year-old man who underwent extended thymothymectomy in 1993 because of an invasive thymoma classified as Masaoka IIa. The tumor was disseminated through the right thoracic cavity in 1994. Although the chemotherapy was repeated, the disseminated thymoma tended to increase in size. The patient was suffering from severe anemia, and pure red cell aplasia was diagnosed in September 2002. The administration of cyclosporin was initiated, and not only brought about improvement of pure red cell aplasia but also tended to shrink the thymoma. Cyclosporin may be an effective drug for the reduction of thymoma as well as for pure red cell aplasia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14584399

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  3 in total

1.  Thymic epithelial tumor complicated by immunological abnormalities: results from a single-center retrospective study in China.

Authors:  Tian-Yan Shi; Xiao-Hong Wen; Xu-Hua Shi; Yue-Wu Lu
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

2.  Cyclosporine is a potential curative treatment option for advanced thymoma.

Authors:  Yusuke Isshiki; Hiroaki Tanaka; Yoshio Suzuki; Yukihiro Yoshida
Journal:  Exp Hematol Oncol       Date:  2017-05-03

3.  Occurrence of acute pulmonary embolism induced by recombinant erythropoietin during treatment of pure red cell aplasia associated with thymoma: A case report.

Authors:  Xiangli Cui; Zirui Wan; Zhuo Ma; Lihong Liu; Yuanhua Yang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.